Monitor shareholder votes and Brazilian antitrust (CADE) approval timeline. The locked-box structure means no post-signing price adjustment, so any material adverse change or regulatory rejection could trigger deal termination without break-up fee. The delisting from Nasdaq and shift to B3-only listing is a key structural change for current U.S. holders.
Price Chart
Executive Summary
Afya Limited announced a binding merger agreement with Yduqs Participações S.A. Under the terms, Afya will merge into Yduqs, with Afya shareholders receiving 6.408347 new Yduqs shares per Afya share and holding 69.0% of the combined company on a fully diluted basis. Afya's Nasdaq listing will be delisted, and the combined company will list solely on B3. The transaction is subject to shareholder and antitrust approvals and must close by March 31, 2028.
Key Facts
- Afya and Yduqs entered into a binding merger agreement on September 23, 2026.
- Exchange ratio: 6.408347 new Yduqs shares per Afya share, based on a locked box date of June 30, 2026.
- Afya shareholders will hold 69.0% and existing Yduqs shareholders 31.0% of the combined company on a fully diluted basis.
- Bertelsmann will hold 47.4% of the combined company.
- Afya's Class A common shares will be delisted from Nasdaq; combined company shares will list solely on B3 under Novo Mercado.
- Break-up fees: R$325 million before shareholder approval; R$650 million after approval if closing conditions are not met.
- Voting agreements in place with Bertelsmann, Nicolau Esteves, Advent, and Chaim Zaher to vote in favor.
- Closing must occur no later than March 31, 2028.
- Conditions include shareholder approval, Brazilian antitrust approval, third-party consents, and no material adverse effect.
- Ineligible U.S. shareholders will receive net cash proceeds from post-closing sale of shares on B3 instead of stock.
Financial Impact
Afya shareholders receive 69.0% of the combined entity; exchange ratio fixed at 6.408347 Yduqs shares per Afya share. Break-up fees of R$325 million (pre-approval) and R$650 million (post-approval) provide deal protection.
Risk Factors
- Shareholder approval not obtained at either company.
- Brazilian antitrust authority (CADE) rejects the transaction.
- Material adverse effect before closing.
- Ineligible U.S. shareholders face uncertainty on cash proceeds from post-closing sale of shares.
- Delisting from Nasdaq removes U.S. exchange liquidity for current holders.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001292814-26-004684 |
| Document: afya20260923_6k.htm | 0001292814-26-004684 |
| Document: 0001292814-26-004684-index-headers.html | 0001292814-26-004684 |
| Document: 0001292814-26-004684-index.html | 0001292814-26-004684 |
| Document: 0001292814-26-004684.txt | 0001292814-26-004684 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 26d ago | 6-K | $12.08 | awaiting T+20 | — | $10.64 (−11.92%) |
Sep 30, 2026 26d ago | 6-K | $12.08 | awaiting T+20 | — | $10.64 (−11.92%) |
Sep 23, 2026 4w ago | 6-K | $13.73 $14.91 | ▲ +8.59% | ▲ +9.01% | $10.64 (−22.51%) |
Sep 18, 2026 5w ago | 6-K | $13.60 $14.53 | ▲ +6.84% | ▲ +6.63% | $10.64 (−21.76%) |
Aug 24, 2026 9w ago | 6-K | $14.22 $13.49 | ▼ −5.13% | ▼ −6.45% | $10.64 (−25.18%) |
Jul 6, 2026 16w ago | Insider Cluster | $14.77 $14.20 | ▼ −3.86% | ▼ −5.19% | $10.64 (−27.96%) |
Jun 30, 2026 16w ago | Insider Cluster | $15.00 $14.75 | ▼ −1.67% | ▲ +0.52% | $10.64 (−29.07%) |
Jun 22, 2026 18w ago | 6-K | $14.36 $13.99 | ▼ −2.58% | ▼ −3.74% | $10.64 (−25.91%) |
Apr 13, 2026 28w ago | Insider Cluster | $15.66 $14.01 | ▲ +10.54% | ▲ +18.26% | $10.64 (+32.06%) |
Apr 6, 2026 29w ago | Insider Cluster | $14.99 $13.98 | ▲ +6.74% | ▲ +15.72% | $10.64 (+29.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers